Sera Prognostics, Inc. (SERA)
2.18
+0.04
(+1.87%)
USD |
NASDAQ |
Aug 24, 16:00
2.15
-0.03
(-1.38%)
After-Hours: 20:00
Sera Prognostics Debt to Equity Ratio : 0.0505 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0505 |
| March 31, 2026 | 0.037 |
| December 31, 2025 | 0.031 |
| September 30, 2025 | 0.0298 |
| June 30, 2025 | 0.004 |
| March 31, 2025 | 0.006 |
| December 31, 2024 | 0.0176 |
| September 30, 2024 | 0.0201 |
| June 30, 2024 | 0.0227 |
| March 31, 2024 | 0.0249 |
| December 31, 2023 | 0.0265 |
| September 30, 2023 | 0.0279 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.029 |
| March 31, 2023 | 0.0286 |
| December 31, 2022 | 0.0286 |
| September 30, 2022 | 0.0127 |
| June 30, 2022 | 0.0137 |
| March 31, 2022 | 0.0119 |
| December 31, 2021 | 0.0009 |
| September 30, 2021 | 0.001 |
| June 30, 2021 | -1.673 |
| March 31, 2021 | -1.454 |
| December 31, 2020 | -1.088 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Myriad Genetics, Inc. | 0.6927 |
| BioRestorative Therapies, Inc. | 0.0114 |
| CareDx, Inc. | 0.0452 |
| Natera, Inc. | 0.1309 |
| Exagen, Inc. | 2.264 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 86.74M |
| Total Liabilities (Quarterly) | 27.36M |
| Shareholders Equity (Quarterly) | 59.38M |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | -0.68% |